Table 2.
Echocardiographic findings according to in-hospital death
| All population | IHM | OR (95% CI) | |||
|---|---|---|---|---|---|
| N = 509 | No, N = 473, 92.9% | Yes, N = 36, 7.1% | p value | ||
| RV > LV | 118 (23.2) | 104 (22.2) | 14 (38.9) | 0.002 | 2.23 (1.1–4.5) |
| D-shape | 59 (12.9) | 48 (11.3) | 11 (32.4) | < 0.001 | 3.73 (1.71–8.14) |
| TAPSE in mm | 20 (18–24) | 21 (18–24) | 17 (14–20) | 0.005 | 0.89 (0.81–0.96) |
| TAPSE < 21 mm | 265 (52.1) | 243 (51.4) | 22 (61.1) | 0.26 | 1.48 (0.74–2.97) |
| TAPSE < 17 mm | 70 (13.8) | 56 (11.8) | 14 (38.9) | < 0.001 | 4.73 (2.3–9.8) |
| sPAP mmhg | 35 (25–50) | 35 (25–50) | 41 (35–50) | 0.051 | 1.02 (0.99–1.05) |
| sPAP > 35 mmHg | 154 (30.3) | 139 (29.4) | 15 (41.7) | 0.122 | 1.71 (0.86–3.42) |
| sPAP > 60 mmHg | 37 (7.3) | 34 (7.2) | 3 (8.3) | 0.79 | 1.17 (0.34–4.02) |
| LVEF in % | 60 (57–63) | 60 (58–64) | 55 (49–60) | 0.022 | 0.94 (0.91–0.97) |
| LVEF 35–55% | 68 (13.4) | 62 (13.1) | 6 (16.7) | 0.54 | 1.32 (0.53–3.31) |
| LVEF < 35% | 14 (2.8) | 10 (2.1) | 4 (11.1) | 0.001 | 5.78 (1.72–19.47) |
|
IVC collapsibility 0 < 50% 1 > 50% |
190 (58.3) | 181 (59) | 9 (47.4) | 0.320 | 0.62 (0.25–1.58) |
| Abnormal hs-cTnI levels | 171 (40.9) | 144 (37.3) | 27 (84.4) | < 0.001 | 9.07 (3.41–24.09) |